Is this the Ariad scam? Pfizer's Crizotinib in ALK-NSCLC; Response Rate "Unprecedented" see for yourselves: http://www.medscape.com/viewarticle/723075 Yet, Ariad's claim is that THEIR ALK is much more effective.. Needless to say, this feels Enron-ish to me... Don, please sort this out!